The impact of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours prior to levonorgestrel-releasing intrauterine system in women delivered only by - Egyptian Knowledge Bank

320849

The impact of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours prior to levonorgestrel-releasing intrauterine system in women delivered only by

Article

Last updated: 03 Jan 2025

Overview Similar Items

Article

A randomized double-blinded clinical trial to explore the clinical outcome of self-administered vaginal isonicotinic acid hydrazide (INH) administration 12 hours before hysterosa

Article

Role of vaginal misoprostol prior to levonorgestrel-releasing IUD insertion

Article

Sublingual misoprostol prior to intra uterine contraceptive device insertion in women with previous cesarean section who had never delivered vaginally

Article

USING OF MISOPROSTOL VAGINALLY PRIOR TO INTRAUTERINE CONTRACEPTIVE DEVICE INSERTION FOLLOWING PREVIOUS INSERTION FAILURE: RANDOMIZED CLINICAL TRIAL

Article

Intrauterine Device Versus Levonorgestrel As Emergency Contraception. Observational Study

Article

Metabolic Changes in Women Using Levonorgestrel Releasing Intrauterine System

Article

Sublingual misoprostol before insertion of levonorgestrel-releasing intrauterine contraceptive device in lactating women following cesarean section

Article

CERVICAL PRIMING WITH SUBLINGUAL MISOPROSTOL PRIOR TO INSERTION OF AN INTRAUTERINE DEVICE IN WOMEN WITH NO PREVIOUS VAGINAL DELIVERY A RANDOMIZED CONTROLLED TRIAL

Article

Effect of Sublingual Misoprostol Prior to Insertion of Intrauterine Device in Women with no Previous Vaginal Delivery

Article

Vaginal Misoprostol Prior to Intrauterine Contraceptive Device Insertion in Women Who Delivered Only By Elective Caesarean Section : Randomized Clinical Trial